Evidence map›Paper›PMID 24732914›Full record

ArticleMolecular & cellular proteomics : MCP2014

Modulation of the chromatin phosphoproteome by the Haspin protein kinase.

Alessio Maiolica, Maria de Medina-Redondo, Erwin M Schoof, Apirat Chaikuad, Fabrizio Villa, Marco Gatti, Siva Jeganathan, Hua Jane Lou, Karel Novy, Simon Hauri and 8 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular & cellular proteomics : MCP, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Haspin kinase binds to a nucleosomal DNA supergroove.Nature structural & molecular biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 6 countries.

Alessio MaiolicaFrom the ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland;
Maria de Medina-Redondo§Department of Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland;
Erwin M Schoof¶Cellular Signal Integration Group (C-SIG), Center for Biological Sequence Analysis (CBS), Department of Systems Biology, Technical University of Denmark (DTU), Lyngby, Denmark;
Apirat Chaikuad‖Oxford University, Nuffield Department of Clinical Medicine, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Oxford OX3 7FZ, United Kingdom;
Fabrizio Villa**Department of Experimental Oncology, European Institute of Oncology, Milan, Italy;
Marco Gatti‡‡Department of Pharmaceutical Sciences, University of Piemonte Orientale "A. Avogadro" Novara, Italy;
Siva Jeganathan§§Department of Mechanistic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany;
Hua Jane Lou¶¶Yale University School of Medicine, Department of Pharmacology, New Haven, Connecticut 06520, USA;
Karel NovyFrom the ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland;
Simon HauriFrom the ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland;
Umut H Toprak§Department of Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland;
Franz Herzog‖‖Gene Center Munich Ludwig-Maximilians-Universität München, Munich, Germany;
Patrick Meraldi§Department of Physiology and Metabolism, Faculty of Medicine, University of Geneva, Geneva, Switzerland;
Lorenza Penengo‡‡Department of Pharmaceutical Sciences, University of Piemonte Orientale "A. Avogadro" Novara, Italy;
Benjamin E Turk¶¶Yale University School of Medicine, Department of Pharmacology, New Haven, Connecticut 06520, USA;
Stefan Knapp‖Oxford University, Nuffield Department of Clinical Medicine, Target Discovery Institute (TDI) and Structural Genomics Consortium (SGC), Oxford OX3 7FZ, United Kingdom;
Rune Linding¶Cellular Signal Integration Group (C-SIG), Center for Biological Sequence Analysis (CBS), Department of Systems Biology, Technical University of Denmark (DTU), Lyngby, Denmark;
Ruedi AebersoldFrom the ‡Department of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich, Switzerland; Faculty of Science, University of Zurich, Zurich, Switzerland aebersold@imsb.biol.ethz.ch.
ETH Zurich · CHUniversity of Geneva · CHTechnical University of Denmark · DKUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · ITUniversity of Oxford · GBYale University · USEuropean Institute of Oncology · ITLudwig-Maximilians-Universität München · DEMax Planck Institute of Molecular Physiology · DE

Funding

Wellcome Trust 092809Wellcome Trust 092809/Z/10/Z
6 · The paper itself

Abstract

Recent discoveries have highlighted the importance of Haspin kinase activity for the correct positioning of the kinase Aurora B at the centromere. Haspin phosphorylates Thr(3) of the histone H3 (H3), which provides a signal for Aurora B to localize to the centromere of mitotic chromosomes. To date, histone H3 is the only confirmed Haspin substrate. We used a combination of biochemical, pharmacological, and mass spectrometric approaches to study the consequences of Haspin inhibition in mitotic cells. We quantified 3964 phosphorylation sites on chromatin-associated proteins and identified a Haspin protein-protein interaction network. We determined the Haspin consensus motif and the co-crystal structure of the kinase with the histone H3 tail. The structure revealed a unique bent substrate binding mode positioning the histone H3 residues Arg(2) and Lys(4) adjacent to the Haspin phosphorylated threonine into acidic binding pockets. This unique conformation of the kinase-substrate complex explains the reported modulation of Haspin activity by methylation of Lys(4) of the histone H3. In addition, the identification of the structural basis of substrate recognition and the amino acid sequence preferences of Haspin aided the identification of novel candidate Haspin substrates. In particular, we validated the phosphorylation of Ser(137) of the histone variant macroH2A as a target of Haspin kinase activity. MacroH2A Ser(137) resides in a basic stretch of about 40 amino acids that is required to stabilize extranucleosomal DNA, suggesting that phosphorylation of Ser(137) might regulate the interactions of macroH2A and DNA. Overall, our data suggest that Haspin activity affects the phosphorylation state of proteins involved in gene expression regulation and splicing.

Indexed as

Amino Acid SequenceAurora Kinase BCell Line, TumorChromatinGene Expression RegulationHEK293 CellsHeLa CellsHistonesHumansIntracellular Signaling Peptides and ProteinsMethylationMitosisNuclear ProteinsPhosphoproteinsPhosphorylationProtein Interaction MapsAURKB protein, humanAurora Kinase BChromatinHASPIN protein, humanHistonesIntracellular Signaling Peptides and ProteinsNuclear ProteinsPhosphoproteinsProtein Serine-Threonine KinasesRNA-Binding ProteinsSerine-Arginine Splicing Factors

Identifiers

PMID24732914
PMCPMC4083111
OpenAlexW2119101756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.